(Bloomberg) -- Richard Saynor wants to transform Sandoz Group AG into a world champion in copying leading-edge drugs, including anti-obesity and biological treatments, with the goal of bringing them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback